Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Hagen

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Neurology|February 1, 1997
Pain in Guillain-Barré syndromeD E Moulin, N Hagen, T E Feasby, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|October 25, 2002
Characterization of mixtures of recombinant human cytochrome p450s as a screening model for metabolic stability in drug discoveryN Hagen, A K Olsen, J V Andersen, et al.
Current Oncology (Toronto, Ont.)|April 20, 2012
Characterizing distress, the 6th vital sign, in an oncology pain clinicA Waller, S L Groff, N Hagen, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|August 20, 1988
[Legionnaires' disease. A current case]Y Tveten, N Hagen, B E Kristiansen, et al.
Advances in Experimental Medicine and Biology|January 1, 1988
The role of high flow capillary channels in the local oxygen supply to skeletal muscleD K Harrison, S Birkenhake, S Knauf, et al.
Neurology|December 1, 1992
Severe phenytoin hypersensitivity with myopathy: a case reportC L Barclay, M McLean, N Hagen, et al.
Journal of Clinical Pharmacology|January 1, 1995
Steady-state pharmacokinetics of hydromorphone and hydromorphone-3-glucuronide in cancer patients after immediate and controlled-release hydromorphoneN Hagen, M P Thirlwell, H S Dhaliwal, et al.
Journal of Pain and Symptom Management|June 1, 1997
A randomized, controlled trial of intravenous clodronate in patients with metastatic bone disease and painD S Ernst, P Brasher, N Hagen, et al.
Cancer|September 15, 1994
Comparative clinical efficacy and safety of immediate release and controlled release hydromorphone for chronic severe cancer painH Hays, N Hagen, M Thirlwell, et al.
Current Oncology (Toronto, Ont.)|October 11, 2014
Recommendations for the referral of patients for proton-beam therapy, an Alberta Health Services report: a model for Canada?S Patel, X Kostaras, M Parliament, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Neurology|February 1, 1997
Pain in Guillain-Barré syndromeD E Moulin, N Hagen, T E Feasby, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|October 25, 2002
Characterization of mixtures of recombinant human cytochrome p450s as a screening model for metabolic stability in drug discoveryN Hagen, A K Olsen, J V Andersen, et al.
Current Oncology (Toronto, Ont.)|April 20, 2012
Characterizing distress, the 6th vital sign, in an oncology pain clinicA Waller, S L Groff, N Hagen, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|August 20, 1988
[Legionnaires' disease. A current case]Y Tveten, N Hagen, B E Kristiansen, et al.
Advances in Experimental Medicine and Biology|January 1, 1988
The role of high flow capillary channels in the local oxygen supply to skeletal muscleD K Harrison, S Birkenhake, S Knauf, et al.
Neurology|December 1, 1992
Severe phenytoin hypersensitivity with myopathy: a case reportC L Barclay, M McLean, N Hagen, et al.
Journal of Clinical Pharmacology|January 1, 1995
Steady-state pharmacokinetics of hydromorphone and hydromorphone-3-glucuronide in cancer patients after immediate and controlled-release hydromorphoneN Hagen, M P Thirlwell, H S Dhaliwal, et al.
Journal of Pain and Symptom Management|June 1, 1997
A randomized, controlled trial of intravenous clodronate in patients with metastatic bone disease and painD S Ernst, P Brasher, N Hagen, et al.
Cancer|September 15, 1994
Comparative clinical efficacy and safety of immediate release and controlled release hydromorphone for chronic severe cancer painH Hays, N Hagen, M Thirlwell, et al.
Current Oncology (Toronto, Ont.)|October 11, 2014
Recommendations for the referral of patients for proton-beam therapy, an Alberta Health Services report: a model for Canada?S Patel, X Kostaras, M Parliament, et al.
Pageof 5